Related Experiment Video
Updated: Feb 9, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Portable impulse-radar detector for breast cancer: a pilot study
Shinsuke Sasada1, Norio Masumoto1, Hang Song2
1Hiroshima University, Research Institute for Radiation Biology and Medicine, Department of Surgical Oncology, Minami-Ku, Hiroshima, Japan.
This study tested a new, portable, radiation-free device that uses radar technology to detect breast tumors. Researchers examined five patients and found the device successfully identified all confirmed cancers, including some that standard mammograms missed. The system proved safe and easy to use, suggesting it could become a helpful tool for early cancer detection.
Area of Science:
- Medical imaging diagnostics within oncology
- Portable impulse-radar detector technology for clinical screening
Background:
Current breast screening techniques often rely on ionizing radiation or complex infrastructure that limits accessibility in resource-constrained settings. That uncertainty drove interest in non-invasive, portable alternatives that avoid harmful exposure. Prior research has shown that microwave-based systems offer a potential pathway for safer diagnostic imaging. No prior work had resolved whether a compact radar-based prototype could maintain clinical accuracy in real-world scenarios. This gap motivated the investigation into a novel handheld device designed for bedside or clinic-based tumor identification. Standard mammography frequently struggles with dense tissue, which can obscure small lesions. Researchers sought to determine if impulse-radar technology might overcome these specific limitations. Establishing the feasibility of such hardware remains a priority for advancing point-of-care oncology diagnostics.
Purpose Of The Study:
The study aimed to evaluate the detective capability and clinical feasibility of a prototype portable breast cancer detector. Researchers sought to determine if an impulse-radar imaging system could reliably identify malignant masses. This investigation addressed the need for non-invasive, radiation-free screening tools that offer improved accessibility. The team focused on verifying whether the device could detect tumors at least 1 cm in diameter. A secondary objective involved assessing the positional accuracy of the radar-based images compared to established diagnostic standards. Investigators also intended to monitor for any adverse events to confirm the safety of the hardware. By testing this prototype, the authors hoped to establish a foundation for future point-of-care oncology applications. This work explores the potential for radar technology to supplement existing breast cancer screening protocols.
Main Methods:
The review approach involved a pilot clinical trial evaluating a novel microwave imaging prototype. Five participants with histologically verified malignancies were enrolled to test the system. Each subject underwent a single 15-minute examination while lying in a supine orientation. The antenna array dome was applied directly to the breast surface to facilitate signal acquisition. Investigators tracked the detection rate as the primary outcome measure for the study. Positional accuracy of the identified masses served as a secondary endpoint for the analysis. The team also monitored for any adverse events to ensure patient safety throughout the procedure. Results were compared against standard diagnostic modalities to confirm the location of all identified tumors.
Main Results:
Key findings from the literature indicate that the radar-based system successfully identified all five targeted breast tumors. The device accurately visualized every lesion at sites confirmed by alternative diagnostic methods. Notably, the technology detected one tumor that mammography missed due to heterogeneously dense tissue. Another successfully identified mass was a microinvasive carcinoma measuring only 0.5 mm in size. No study-related adverse events occurred during the observation period for any participant. The prototype demonstrated sufficient detective capability across all enrolled cases. These results highlight the potential of the system to function effectively in a clinical environment. The data suggest that the radar approach provides a viable alternative for tumor identification.
Conclusions:
The authors propose that the radar-based prototype demonstrates sufficient sensitivity for identifying malignant breast masses. This system appears safe for patient application, as no negative side effects were reported during the trials. The researchers suggest that the device might identify early-stage tumors, including those categorized as noninvasive. One notable finding involves the successful visualization of lesions that standard mammography failed to capture. The team emphasizes that the technology could serve as a valuable supplement to existing diagnostic workflows. Future work should prioritize reducing the physical dimensions of the hardware to improve portability. Shortening the duration of the examination process represents another goal for subsequent iterations of the system. These findings support the continued development of radar-based imaging for broader clinical integration.
Frequently Asked Questions
The researchers propose that the device identifies tumors by capturing microwave reflections. This mechanism successfully located all five confirmed malignancies, including one missed by mammography and a 0.5 mm microinvasive carcinoma, demonstrating its potential to visualize lesions that standard imaging techniques might overlook in dense breast tissue.
The system utilizes an antenna array dome. This component is placed directly onto the patient's skin while they remain in a supine position, allowing the radar signals to penetrate the tissue for a 15-minute examination period to generate the required diagnostic data.
The authors state that a supine position is necessary for the examination. This orientation ensures stable contact between the antenna array dome and the breast, which is required to maintain signal consistency and positional accuracy throughout the 15-minute scanning duration.
The study relies on histological confirmation as the gold standard for data validation. This clinical evidence confirms the presence and location of the five tumors, allowing researchers to compare the radar-based imaging results against established diagnostic modalities to verify detection accuracy.
The researchers measured the detection rate as the primary endpoint. Secondary metrics included positional accuracy and the occurrence of adverse events, ensuring a comprehensive evaluation of both the diagnostic capability and the safety profile of the portable radar system during the pilot phase.
The authors suggest that future developments should focus on decreasing the machine's physical size and shortening the inspection time. These improvements are intended to enhance the practicality and efficiency of the device for routine clinical use in diverse healthcare settings.
Related Concept Videos
Impulse
Additionally, it can be shown that the...
Impulse Response
Kirchhoff's law forms an input signal equation, with the capacitor's current and voltage providing the output. Substituting the current and dividing by RC yields a differential equation. The output for an impulse input is the impulse...
Pilot and Numeric Relaying
Gas Chromatography: Types of Detectors-I
TCD is the earliest and most widely used detector that operates by measuring the changes in the thermal conductivity of the carrier gas. When a sample compound enters the detector,...
Principle of Impulse and Moment
Impulse-Momentum Theorem
By writing Newton's second law of motion in terms of the momentum of an object and the external force acting on it, and simultaneously using the definition of the impulse vector, it can be shown that the total impulse on an object is equal to its...

